Editorial: Mitochondrial damage interacts with the immune system and tumor microenvironment.
作者信息
Lin Xundong, Yuan Xin, Luo Yiheng, Fang Haihong, Guo Weihong
机构信息
Nanfang Hospital, Southern Medical University, Guangzhou, China.
出版信息
Front Immunol. 2025 Jun 30;16:1646413. doi: 10.3389/fimmu.2025.1646413. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Mitochondrial damage interacts with the immune system and tumor microenvironment.
Front Immunol. 2025 Jun 30;16:1646413. doi: 10.3389/fimmu.2025.1646413. eCollection 2025.
2
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion.
J Immunother Cancer. 2025 Jul 15;13(7):e010926. doi: 10.1136/jitc-2024-010926.
3
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
4
Piperlongumine enhances the antitumor efficacy of PD-1 inhibitors by inducing immunogenic cell death in prostate cancer cells.
World J Urol. 2025 Jul 2;43(1):406. doi: 10.1007/s00345-025-05760-9.
5
CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenvironment.
Cancer Lett. 2024 Apr 28;588:216595. doi: 10.1016/j.canlet.2023.216595. Epub 2023 Dec 12.
6
Membrane-Coated Hollow Manganese Nitrogen Carbon Nanocomposites Synergize Phototherapy and STING Activation for Immunogenic Tumor Microenvironment Remodeling.
ACS Appl Mater Interfaces. 2025 Jun 25;17(25):37053-37067. doi: 10.1021/acsami.5c05076. Epub 2025 Jun 11.
7
Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.
Thyroid. 2024 Aug;34(8):999-1006. doi: 10.1089/thy.2024.0072. Epub 2024 Jul 12.
8
PMN-MDSCs are responsible for immune suppression in anti-PD-1 treated TAP1 defective melanoma.
Clin Transl Oncol. 2025 Jan 18. doi: 10.1007/s12094-024-03840-7.
9
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.
J Immunother Cancer. 2025 Jun 23;13(6):e012066. doi: 10.1136/jitc-2025-012066.
10
Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.
Front Immunol. 2025 Jun 20;16:1598436. doi: 10.3389/fimmu.2025.1598436. eCollection 2025.
本文引用的文献
1
Mitochondria and cell death.
Nat Cell Biol. 2024 Sep;26(9):1434-1446. doi: 10.1038/s41556-024-01429-4. Epub 2024 Jun 20.
2
Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging.
Nat Commun. 2024 Jan 27;15(1):830. doi: 10.1038/s41467-024-45044-1.
3
Targeting Erbin-mitochondria axis in platelets/megakaryocytes promotes B cell-mediated antitumor immunity.
Cell Metab. 2024 Mar 5;36(3):541-556.e9. doi: 10.1016/j.cmet.2023.12.020. Epub 2024 Jan 16.
4
Copper homeostasis and cuproptosis in mitochondria.
Life Sci. 2023 Dec 1;334:122223. doi: 10.1016/j.lfs.2023.122223. Epub 2023 Oct 29.
5
Role of mitochondrial alterations in human cancer progression and cancer immunity.
J Biomed Sci. 2023 Jul 31;30(1):61. doi: 10.1186/s12929-023-00956-w.
6
Raddeanin A Enhances Mitochondrial DNA-cGAS/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43.
Adv Sci (Weinh). 2023 May;10(13):e2206737. doi: 10.1002/advs.202206737. Epub 2023 Mar 6.
7
Top 10 Challenges in Cancer Immunotherapy.
Immunity. 2020 Jan 14;52(1):17-35. doi: 10.1016/j.immuni.2019.12.011.
8
Mitochondria are the powerhouses of immunity.
Nat Immunol. 2017 Apr 18;18(5):488-498. doi: 10.1038/ni.3704.
Zotero 插件